Neste trabalho descreve-se o estudo química dos extratos de quatro esponjas e dois fungos de origem marinha oriundos da costa do Brasil. Os extratos de três esponjas (Petromica ciocalyptoides, Topsentia ophiraphidites e Callyspongia sp.) apresentaram atividade inibitória à enzima adenosina fosforribosil transferase de Leishmania tarentolae. A partir desses extratos foram isolados 4 compostos. O trissulafato de halistanol, isolado das esponjas P. ciocalyptoides e T. ophiraphidites, e o ilhabelanol, ilhabreno e isoakaterpina, isolados da esponja Callyspongia sp. A partir do extrato bruto da esponja Axinella cf corrugata foram isolados dois derivados cumarínicos, provavelmente artefatos de isolamento do ácido 4-esculetínico, o qual é inédito como produto natural. O extrato bruto da esponja Axinella cf. corrugata apresentou atividade citotóxica, mas os compostos puros não apresentaram esta atividade. Os dois compostos puros foram testados ainda quanto sua atividade contra o vírus da SARS, na qual o éster etílico do ácido 4-esculetínico se apresentou ativo. A partir de dois extratos oriundos do fungo Beauveria felina, isolado da alga marinha Caulerpa sp, foram isoladas 17 frações puras que após diversas análises foram agrupadas em seis compostos conhecidos na literatura: a (Phe3, N-Val5) destruxina B, a cloroidrina da destruxina E, a roseotoxina B, a roseocardina, a isariina e a isariina B. Além disso, foram isolados dois compostos inéditos, a pseudodestruxina C e a cloloidrina Beta-Me-Pro da destruxina E. Os extratos brutos de Beauveria felina apresentaram atividades em bioensaios de atividade antituberculose e de citotoxicidade em linhagem de células de câncer. Os compostos puros avaliados no bioensaio antituberculose não foram ativos. Somente o composto roseotoxina B apresentou atividade citotóxica in vitro para quatro linhagens de células: mama, cólon, sistema nervoso e leucemia. / In this work we report the chemical investigation of bioactive crude extracts obtained from four sponges and two fungal strains of marine origin. The crude extracts of three sponges species (Petromica ciocalyptoides, Topsentia ophiraphidites and Callyspongia sp.) displayed inhibitory activity towards the enzyme adenine fosforribosyl transferase of Leishmania tarentolae (L-APRT). Four compounds have been isolated from these extracts: the known halistanol sulfate was isolated of sponges P. ciocalyptoides and T. ophiraphidites, while the novel ilhabelanol, ilhabrene and isoakaterpin have been isolated from the sponge Callyspongia sp. All compounds exhibited inhibition of L-APRT at micro M concentrations. Two coumarin derivatives have been isolated from the crude extract of the sponge Axinella cf. corrugata, probably as artifacts of isolation: esculetin-4-carboxylic acid methyl ester and esculetin-4-carboxylic acid ethyl ester. While the crude extract of the sponge Axinella cf. corrugata presented cytotoxic activity, the pure compounds were inactive in these assays. The esculetin-4-carboxylic acid ethyl ester was found to be an in vitro inhibitor of SARS virus. The crude extract obtained of a marine-derived Beauveria felina strain, isolated from the alga Caulerpa sp., displayed antituberculosis activity against Mycobacterium tuberculosis H37Rv and cytotoxic activity against MCF-7 (breast), HCT-8 (colon) and B16 (murine melanoma) cancer cell lines. Chemical fractionation of the crude extract led to the isolation of two new cyclodepsipeptides pseudodestruxin C and [Beta-Me-Pro] destruxin E chlorohydrin, and of the known destruxin E chlorohydrin, [Phe3, N-Me-Val5] destruxin B, roseotoxin B, roseocardin, isariin and isariin B. The depsipeptides [Phe3, NMe- Val5] destruxin B and rosetoxin B, have been tested against M. tuberculosis H37 Rv and in cytotoxicity bioassays against SF 295 (human CNS) MDA-MB435 (human breast) HCT8 (colon) and HL60 (leukemia) cancer cell lines. Only roseotoxin B displayed moderate cytotoxicity against the cancer cell lines.

The projects described in this dissertation concentrated on investigating Caribbean species for qualitative and quantitative chemical differences. Chapter one includes a brief update on the status of natural products as drugs, a discussion of the biodiversity of Caribbean marine organisms as well as a discussion about the chemistry of algae and sponges. In chapter two, an experiment to test for possible effects of warmer, more acidic water and how that will impact coral reef organisms was conducted. Six common Caribbean coral reef sponge species were grown in seawater for 24 days ranging from values experienced at summer-maxima (temperature = 28 ºC; pH = 8.1) to those predicted for the year 2100 (T = 31 ºC; pH = 7.8). For each species, attachment rates, growth, and survival were similar between temperature and pH levels. Only two metabolite concentrations varied significantly between treatments but were similar to baseline levels. In chapter three, a chemical survey of Florida Keys algae was performed using MeOH extraction and HP-20 SPE with varying Me2CO:H2O solutions. 1H NMR spectra were collected for each fraction and analyzed for interesting signals. A Laurencia sp. was extracted and found to contain the known compound isodactylyne (61) with the structure determined using spectroscopic analyses. In chapter four, a Laurencia obtusa specimen was investigated to determine the compound causing oxygenated signals between 4.50 – 4.80 ppm in the 1H NMR spectra observed in chapter three. A large scale extraction and fractionation was performed and the compound was determined to be 1-O-palmitoyl-2-O-myristoyl-3-O-(6-sulfo-α- D-quinovo-pyranosyl)-glycerol (63). In chapter five, the isolation and structural elucidation of a new compound, furocaespitanenone (64) and two known compounds (10R)- and (10S)-10-O-methylfurocaespitanelactol 65 and 66, from a Laurencia sp. collected off of the Florida Keys using MeOH extraction and HP-20 column chromatography is described. A potential biosynthesis of 64 from furocaepsitane (68) is proposed. / Includes bibliography. / Dissertation (Ph.D.)--Florida Atlantic University, 2019. / FAU Electronic Theses and Dissertations Collection

Marine sponge-associated actinomycetes are reservoirs of diverse natural products with novel biological activities. Their antibiotic potential has been well explored against a range of Gram positive and negative bacteria. However, not much is known about their anti-infective or anti-virulence potential against human pathogens. This Ph.D. project aimed to investigate the anti-infective (anti-Shiga toxin and anti-biofilm) potential of sponge-derived actinobacteria through identification and isolation of their bioactive metabolites produced and characterizing their mechanism of action by transcriptomics. This thesis is divided into three studies with the overall objective of exploring the anti-infective efficacy of actinomycetes-derived extracts and compound(s) that could possibly be used as future therapeutics. The first study deals with investigation on the anti-Shiga toxin effects of sponge-associated actinomycetes. Diarrheal infections pose a huge burden in several developing and developed countries. Diarrheal outbreaks caused by Enterohemorrhagic Escherichia coli (EHEC) could lead to life-threatening complications like gastroenteritis and haemolytic uremic syndrome (HUS) if left untreated. Shiga toxin (Stx) produced by EHEC is a major virulence factor that negatively affects the human cells, leading them to death via apoptosis. Antibiotics are not prescribed against EHEC infections since they may enhance the risk of development of HUS by inducing the production and release of Stx from disintegrating bacteria and thereby, worsening the complications. Therefore, an effective drug that blocks the Stx production without affecting the growth needs to be urgently developed. In this study, the inhibitory effects of 194 extracts and several compounds originating from a collection of marine sponge-derived actinomycetes were evaluated against the Stx production in EHEC strain EDL933 with the aid of Ridascreen® Verotoxin ELISA assay kit. It was found that treatment with the extracts did not lead to significant reduction in Stx production. However, strepthonium A isolated from the culture of Streptomyces sp. SBT345 (previously cultivated from the Mediterranean sponge Agelas oroides) reduced the Stx production (at 80 μM concentration) in EHEC strain EDL933 without affecting the bacterial growth. The structure of strepthonium A was resolved by spectroscopic analyses including 1D and 2D-NMR, as well as ESI-HRMS and ESI-HRMS2 experiments. This demonstrated the possible application of strepthonium A in restraining EHEC infections. VI In the second study, the effect of marine sponge-associated actinomycetes on biofilm formation of staphylococci was assessed. Medical devices such as contact lenses, metallic implants, catheters, pacemakers etc. are ideal ecological niches for formation of bacterial biofilms, which thereby lead to device-related infections. Bacteria in biofilms are multiple fold more tolerant to the host immune responses and conventional antibiotics, and hence are hard-to-treat. Here, the anti-biofilm potential of an organic extract derived from liquid fermentation of Streptomyces sp. SBT343 (previously cultivated from the Mediterranean sponge Petrosia ficiformis) was reported. Results obtained in vitro demonstrated its anti-biofilm (against staphylococci) and non-toxic nature (against mouse macrophage (J774.1), fibroblast (NIH/3T3) and human corneal epithelial cell lines). Interestingly, SBT343 extract could inhibit staphylococcal biofilm formation on polystyrene, glass and contact lens surfaces without affecting the bacterial growth. High Resolution Fourier Transform Mass Spectrometry (HR-MS) analysis indicated the complexity and the chemical diversity of components present in the extract. Preliminary physio-chemical characterization unmasked the heat stable and non-proteinaceous nature of the active component(s) in the extract. Finally, fractionation experiments revealed that the biological activity was due to synergistic effects of multiple components present in the extract. In the third study, anti-biofilm screening of 50 organic extracts generated from solid and liquid fermentation of 25 different previously characterized sponge-derived actinomycetes was carried out. This led to identification of the anti-biofilm organic extract derived from the solid culture of Streptomyces sp. SBT348 (previously cultivated from the Mediterranean sponge Petrosia ficiformis). Bioassay-guided fractionation was employed to identify the active fraction Fr 7 in the SBT348 crude extract. Further purification with semi-preparative HPLC led to isolation of the bioactive SKC1, SKC2, SKC3, SKC4 and SKC5 sub-fractions. The most active sub-fraction SKC3 was found to be a pure compound having BIC90 and MIC values of 3.95 μg/ml and 31.25 μg/ml against S. epidermidis RP62A. SKC3 had no apparent toxicity in vitro on cell lines and in vivo on the greater wax moth Galleria melonella larvae. SKC3 was stable to heat and enzymatic treatments indicating its non-proteinaceous nature. HR-MS analysis revealed the mass of SKC3 to be 1258.3 Da. Structure elucidation of SKC3 with the aid of 1D and 2D-NMR data is currently under investigation. Further, to obtain insights into the mode of action of SKC3 on S. epidermidis RP62A, RNA sequencing was done. Transcriptome data revealed that SKC3 was recognized by RP62A at 20 min and SKC3 negatively interfered with the central metabolism of staphylococci at 3 h. Taken VII together, these findings suggest that SKC3 could be a lead structure for development of new anti-staphylococcal drugs. Overall, the results obtained from this work underscore the anti-infective attributes of actinomycetes consortia associated with marine sponges, and their applications in natural product drug discovery programs. / Meeresschwamm-assoziierte Actinomyceten stellen ein Reservoir für verschiedene natürliche Produkte mit neuartigen biologischen Aktivitäten dar. Ihr antibiotisches Potenzial gegenüber einer Reihe von Gram-negativen und -positiven Bakterien ist bereits intensiv erforscht worden. Wenig ist allerdings über ihre antiinfektive und antivirulente Wirksamkeit gegenüber menschlichen Pathogenen bekannt. Ziel dieser Doktorarbeit war es, die antiinfektiven Fähigkeiten (anti-Shiga-Toxin und anti-Biofilm) der aus Schwämmen isolierten Actinobakterien zu untersuchen. Hierfür wurden bioaktive Metabolite der Actinobakterien identifiziert und isoliert und abschließend wurde ihr Wirkmechanismus mit Hilfe einer Transkriptomanalyse charakterisiert. Diese Arbeit ist in drei Studien gegliedert, welche alle zum Ziel hatten die antiinfektive Wirksamkeit von aus Actinomyceten gewonnenen Extrakten und Komponente(n), welche möglicherweise als zukünftige Therapeutika dienen könnten, zu untersuchen. Die erste Studie befasst sich mit den anti-Shiga-Toxin Effekten der Meeresschwamm- assoziierten Actinomyceten. Durchfallinfektionen stellen in vielen Entwicklungsländern aber auch in Industrieländern eine große Gefahr dar. Durchfallerkrankungen die durch enterohämorrhagische Escherichia coli (EHEC) hervorgerufen werden, können sich zu lebensbedrohlichen Komplikationen wie Gastroenteritis oder dem hämolytisch urenischen Syndrom (HUS) weiterentwickeln. Das von den EHEC Stämmen produzierte Shiga-Toxin (Stx) stellt hierbei den Haupt Virulenz Faktor dar, welcher die eukaryotische Proteinsynthese menschlicher Zellen negativ beeinflusst, was wiederum den Zelltod durch Apoptose zur Folge hat. Die Behandlung der EHEC-Patienten mit Antibiotika wird nicht empfohlen, da dies zu einem Anstieg von freigesetztem Stx der zersetzen Bakterien führen könnte, wodurch das Risiko für die Entwicklung des HUS ansteigt. Aus diesem Grund werden effektive Medikamente dringen benötigt, welche die Stx Produktion blockieren ohne das Wachstum der Bakterien zu beeinflussen. In dieser Studie wurden 194 Extrakte und einige isolierte Komponenten von aus Schwämmen gewonnenen Actinomyceten auf ihren negativen Einfluss auf die Stx Produktion des EHEC Stammes EDL933 mit der Hilfe des Ridascreen® Verotoxin ELISA Kits untersucht. Es konnte gezeigt werden, dass die Zugabe der Extrakte keinen signifikanten Einfluss auf die Stx Produktion hatte. Strepthonium A auf der anderen Seite, welches aus Streptomyces sp. SBT345 isoliert wurde (vom mediterranen Schwamm Agelas oroides) konnte die Stx Produktion von EDL933 bei einer Konzentration von 80 µM reduzieren ohne das Wachstum des EHEC Stammes zu beeinflussen. Die Struktur von Strepthonium A wurde mittels spektroskopischer Analyse (1D- und 2D-NMR), sowie mittels ESI-HRMS und ESI-HRMS2 Experimenten entschlüsselt. Basierend auf diesen Ergebnissen könnte Strepthonium A eine mögliche Alternative oder Zusatz in der Behandlung einer EHEC Infektion darstellen. In der zweiten Studie wurde der Einfluss der Meeresschwamm-assoziierten Actinomyceten auf die Biofilmbildung von Staphylokokken bewertet. Medizinische Produkte wie Kontakt Linsen, metallische Implantate, Katheter, Herzschrittmacher, usw. stellen optimale ökologische Nischen für die Ausbildung von bakteriellen Biofilmen dar, wodurch Infektionen im Menschen hervorgerufen werden können. Bakterien in einem Biofilm sind deutlich toleranter gegenüber der Immunantwort ihres Wirtes sowie gegenüber konventionellen Antibiotika und sind daher schwer zu bekämpfen. In dieser Studie wurde das anti-Biofilm Potential eines organischen Extrakts der flüssigen Fermentation von Streptomyces sp. SBT343 (vom mediterranen Schwamm Petrosia ficiformis) ermittelt. In vitro Ergebnisse zeigten, dass das organische Extrakt anti-Biofilm (gegenüber Staphylococci) Fähigkeiten besitzt und nicht toxisch für Maus Makrophagen (J774.1), Fibroblasten (NIH/3T3) und humane korneale Epithelzellen ist. Zudem konnte gezeigt werden, dass das SBT343 Extrakt die Ausbildung eines Biofilms von Staphylokokken auf den Oberflächen von Polystyrol, Glass und Kontaktlinsen unterbinden konnte ohne das bakterielle Wachstum zu beeinflussen. Die hochauflösende Fouriertransformation-Massenspektrometrie (HR-MS) Analyse konnte die Komplexität sowie die chemische Vielfalt an Komponenten im Extrakt aufzeigen. Eine vorläufige, physio-chemische Charakterisierung deutet darauf hin, dass die aktive Komponente im Extrakt hitzestabil und nicht proteinartiger Natur ist. Abschließend konnte durch Fraktionierungsexperimente gezeigt werden, dass die biologische Aktivität auf synergistischen Effekten mehrerer Komponenten im Extrakt beruht. In einer dritten Studie wurden 50 organische Extrakte, welche aus fester und flüssiger Fermentierung von 25 verschiedenen aus Meeresschwämmen isolierten Actinomyceten gewonnen wurden, auf anti-Biofilm-Aktivität untersucht. Hierbei wurde die anti-Biofilm Aktivität des organischen Extrakts der Festkultur von Streptomyces sp. SBT348 (vom mediterranen Schwamm Petrosia ficiformis) identifiziert. Eine Bioassay gestützte Fraktionierung führte zu der Identifikation der aktiven Fraktion Fr 7 im SBT348 Extrakt. Durch weitere Aufreinigung des Extrakts mit einer semipräparativen HPLC, konnten die bioaktiven Sub-Fraktionen SKC1, SKC2, SKC3, SKC4 und SKC5 isoliert werden. Die Sub- Fraktion SKC3 hatte den stärksten anti-Biofilm Effekt und bestand aus einer reinen Verbindung mit BIC90 und MIC Werten von 3,95 µg/ml und 31,25 µg/ml gegen S. epidermidis RP62A. SKC3 zeigte weder erkennbare Toxizität gegenüber Zelllinien in vitro noch gegenüber den Larven der großen Wachsmotte Galleria melonella in vivo. SKC3 war Hitze- und Enzym-resistent, was auf eine nicht proteinartige Natur hindeutet. Eine HR-MS Analyse ergab, dass die Masse von SKC3 1258,3 Da beträgt. Die Strukturanalyse von SKC3 durch 1D und 2D-NMR ist zurzeit in Bearbeitung. Um weiteres Verständnis über den anti-Biofilm Wirkmechanismus von SKC3 auf S. epidermidis RP62A zu erlangen, wurde eine RNA Sequenzierungsanalyse durchgeführt. Die Transkriptomanalyse zeigte, dass SKC3 von RP62A nach einer 20-minütigen Inkubationszeit erkannt wird und dass SKC3 den zentralen Metabolismus des Staphylokokken Stammes nach 3 h negativ beeinflusst. Zusammengenommen deuten die Ergebnisse darauf hin, dass SKC3 als Leitstruktur für die Entwicklung neuer anti- Staphylokokken Medikamente dienen könnte. Zusammenfassend heben die Ergebnisse dieser Arbeit die antiinfektiven Eigenschaften der Meeresschwamm-assoziierte Actinomyceten hervor und bieten eine Möglichkeit für die Nutzung dieser in Wirkstoffentwicklungsprogrammen.

In the fight against disease and illness, nature has provided mankind some of our best therapeutics in the form of secondary metabolites. The plant, fungi and animal phyla inhabiting the Earth produce diverse and unique chemistry that can be used in our fight against disease. In the growing threat of drug resistance and pathogen evolution, the field of natural products chemistry strives to explore new biological and chemical diversity sources, and develop innovative methodology to identify and isolate new chemistry faster than ever. The dissertation herein presented is one such effort to find new, bioactive chemistry from the marine environments. New biodiversity sources, from the tropical Floridian mangrove forests to the cold waters of the Antarctic oceans, were evaluated for the new, unique chemistry they produce. A large-scale screening of epigenetically modulated mangrove fungi was undertaken, producing a large, biologically and chemically diverse extract library. New methodology was developed in order to evaluate these extracts, leading to rapid identification and isolation of known and new bioactive metabolites. From the Southern Oceans, a collection of sponges was studied, and a new, highly unique peptide was isolated and characterized. These efforts were undertaken in the continued effort to isolate new, unique lead compounds.

An investigation of the dichioromethane extract of the sponge, Xestospongia testudinaria indicated that the extract was composed of approximately 40% sterols, 30% saturated fatty acids, 10% mono-unsaturated fatty acids and 20% poly-unsaturated acids. The sterol profile was found to vary between two collections of the sponge. In the first collection the major sterol was the C30 compound, xestosterol (4), which had not previously been reported to occur in this species. In the second collection there was a wider distribution of components with cholesterol (2a) being a major constituent and xestosterol being present in a much lower percentage than in the first collection. The poly-unsaturated acid fraction contained an extremely complex mixture. The novel brominated bisacetylenic C18 (47) and brominated C28 (65) acids were found to be the major components. Another six novel brominated acetylenic acids, which were very unstable, were also identified as well as an ester of 4 with 47. The method developed for the separation of the poly-unsaturated acids from the other classes of metabolites and for the isolation of the pure compounds is discussed and their structural elucidation, largely on the basis of NIMR spectroscopy is described. From the hexane extract of Carteriospongia foliascens, two novel bisalkylated norscalarane derivatives (114 and 116) and a bisalkylated scalarane derivative (130) have been isolated. By use of high field NMR and multipulse NMR techniques a complete assignment of the 111 and 13C NMR spectra of 130 has been achieved on 1.5mg of material. This represents the first report of a complete assignment of the 1J4 NMR spectrum of a scalarane derivative. The C-4 stereochemistry of 130 was determined by use of 1H NMR spectroscopic techniques, which gave results in agreement with the previously used 13C NMR method.

Isolation and structure elucidation of natural products from marine sponges and an invertebrate were performed. The marine sponges and invertebrate were obtained from three locations including South East Queensland, in Australia, Pontianak in West Kalimantan, and Tulamben, in Bali, Indonesia. The natural products were purified using chromatographic techniques, the structures were elucidated by means of extensive 1D and 2D NMR spectroscopy and some were confirmed by X-ray crystallography. Five known compounds and potentially a new metabolite were identified from three different sponges and a species of nudibranch obtained in Mooloolaba, South East Queensland in Australia. Furospinosulin-1 (4.5), a linear sesterterpenoid, was identified from a sponge coded 20-1-07-1-7 while imidazole alkaloids, preclathridine A (4.9) and clathridine (4.10), were characterized from sponge 22-4-07-2-1. The ethyl acetate extract of sponge 14-7-07-1-1 yielded a polyacetylene fulvinol-like compound (4.15) and potentially a new metabolite compound 5 (4.21). Additionally, a specimen of Chromodoris kuiteri furnished a cyclic macrolide latrunculin A (4.27). There were six secondary metabolites identified from Aaptos aaptos, two of which to the best of our knowledge were new compounds. Aaptamine (5.1), a chemotaxonomic marker of the sponge A. aaptos, 9-demethylaaptamine (5.3) and a biosynthetically unrelated compound (-)-jaspamide (5.31) were found as major constituents of the dichloromethane extract of the sponge. On the other hand, a known indole-3-carbaldehyde (5.10), and the two new natural products methyl 3-(8,9-dimethoxy-4H-benzo[de][1,6]naphthyridin-4-yl)propanoate (5.11) and 8,9-dimethoxy-4H-benzo[de][1,6]naphthyridine-5,6-dione (5.30) were isolated as minor components. During a two-month fieldwork trip to Tulamben, Bali, six different sponges were obtained. Investigation of a blue colored sponge Petrosia sp. afforded two isoquinolinequinone metabolites, namely mimosamycin (5.35) and O-demethylrenierone (5.36). A new 3-alkylpiperidine metabolite, tetradehydrohaliclonacyclamine A (6.28), was isolated from a sponge Halichondria sp. The structure and relative stereochemistry of 6.28 were determined from analysis of 2D NMR data and interpretation of coupling constants. Suitable crystals that were grown from hexane: ethyl acetate (1:3) allowed the determination of the absolute configuration of 6.28 and it was established to be 2S, 3S, 7S, and 9S on the basis of X-ray crystallographic data. The isolated compound (6.28) appeared to be as a single enantiomer according to chiral HPLC. The parent compounds, haliclonacyclamine A (6.19) and B (6.20), were re-isolated from a sample (coded BK-Hal-12-AIK) obtained from a previous project on Haliclona in our group. Their absolute configurations were determined for the first time by X-ray crystallography and they were established to be 2R, 3R, 7R, and 9R.

Graduation date: 1993

No description available.

Samples of Porites porites rubble were collected from across three fringing reefs which lie along a eutrophication gradient in Barbados, West Indies. The coral skeleton fragments were examined for clionid sponges. Data collected from the reef crest and fore reef zones and from across the range of distances and depths were pooled for each reef to compare indices of sponge abundance along the eutrophication gradient. Significant differences between the reefs were found for the proportion of rubble invaded (ANCOVA, p = 0.004), number of invasions per sample (ANCOVA, p = 0.002), and number of species per sample (ANCOVA, p = 0.018) but not for total surface area of sponge invasions per sample (ANCOVA, p = 0.064). All the indices demonstrated an increase with increasing eutrophication level. Clionids were found in nearly twice as many of the pieces collected from the most eutrophic site (41%) as from the least eutrophic (24%). Since clionids may be the principal bioeroders of coral reefs, an increase in their abundance due to excessive pollution likely results in greater bioerosion of affected reefs. The mean abundance of Type 3 corals was found to be positively related to the frequency of boring sponge invasion, suggesting that increased bioeroision may be partly responsible for community shifts toward Type 3 corals in polluted waters. One new variety and three new species of boring sponges of the genus Cliona were found. A new variety of C. amplicavata Rutzler is described, Cliona species 2 of MacGeachy is redescribed and Cliona species 4 and Cliona species 5 are described for the first time. Cliona species 5 may become an important bioeroder in Barbados and other Caribbean islands since it flourishes under high eutrophic conditions which are beginning to plague West Indian reefs. (Abstract shortened by UMI.)

Isolation and structure elucidation of natural products from marine sponges and an invertebrate were performed. The marine sponges and invertebrate were obtained from three locations including South East Queensland, in Australia, Pontianak in West Kalimantan, and Tulamben, in Bali, Indonesia. The natural products were purified using chromatographic techniques, the structures were elucidated by means of extensive 1D and 2D NMR spectroscopy and some were confirmed by X-ray crystallography. Five known compounds and potentially a new metabolite were identified from three different sponges and a species of nudibranch obtained in Mooloolaba, South East Queensland in Australia. Furospinosulin-1 (4.5), a linear sesterterpenoid, was identified from a sponge coded 20-1-07-1-7 while imidazole alkaloids, preclathridine A (4.9) and clathridine (4.10), were characterized from sponge 22-4-07-2-1. The ethyl acetate extract of sponge 14-7-07-1-1 yielded a polyacetylene fulvinol-like compound (4.15) and potentially a new metabolite compound 5 (4.21). Additionally, a specimen of Chromodoris kuiteri furnished a cyclic macrolide latrunculin A (4.27). There were six secondary metabolites identified from Aaptos aaptos, two of which to the best of our knowledge were new compounds. Aaptamine (5.1), a chemotaxonomic marker of the sponge A. aaptos, 9-demethylaaptamine (5.3) and a biosynthetically unrelated compound (-)-jaspamide (5.31) were found as major constituents of the dichloromethane extract of the sponge. On the other hand, a known indole-3-carbaldehyde (5.10), and the two new natural products methyl 3-(8,9-dimethoxy-4H-benzo[de][1,6]naphthyridin-4-yl)propanoate (5.11) and 8,9-dimethoxy-4H-benzo[de][1,6]naphthyridine-5,6-dione (5.30) were isolated as minor components. During a two-month fieldwork trip to Tulamben, Bali, six different sponges were obtained. Investigation of a blue colored sponge Petrosia sp. afforded two isoquinolinequinone metabolites, namely mimosamycin (5.35) and O-demethylrenierone (5.36). A new 3-alkylpiperidine metabolite, tetradehydrohaliclonacyclamine A (6.28), was isolated from a sponge Halichondria sp. The structure and relative stereochemistry of 6.28 were determined from analysis of 2D NMR data and interpretation of coupling constants. Suitable crystals that were grown from hexane: ethyl acetate (1:3) allowed the determination of the absolute configuration of 6.28 and it was established to be 2S, 3S, 7S, and 9S on the basis of X-ray crystallographic data. The isolated compound (6.28) appeared to be as a single enantiomer according to chiral HPLC. The parent compounds, haliclonacyclamine A (6.19) and B (6.20), were re-isolated from a sample (coded BK-Hal-12-AIK) obtained from a previous project on Haliclona in our group. Their absolute configurations were determined for the first time by X-ray crystallography and they were established to be 2R, 3R, 7R, and 9R.